The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 22.02.2026. Verfasst von Wenting Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Zhangjiagang TCM Hospital Affil…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Adenosine, Computational Biology. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Jiangsu Province, Gusu Health Talent Plan Research Project.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder, the molecular underpinnings of which remain largely undefined. The most common methylation modification of RNA, N 6 ‐methyladenosine (m6A), plays an important role in various reproductive and endocrine disorders. This study investigates key m6A genes in PCOS and their association with immune cell infiltration using advanced bioinformatics methods.
Methods
We utilized gene expression data and clinical information from the Gene Expression Omnibus database data sets GSE137684, GSE80432, and GSE114419. The expression of m6A‐related genes was analyzed across all samples. Using the GSVA and CIBERSORT packages in R, we developed a diagnostic model based on the m6A gene–protein interaction network, conducted enrichment analysis of hub genes, and assessed the correlation between these genes and immune cell infiltration.
Results
Analysis of data sets GSE137684 and GSE804322 identified variable expression patterns among three categories of m6A genes. A diagnostic model centered on m6A gene expression was established, highlighting five genes—WTAP, METTL14, ZC3H13, PCIF1, and RBM15—with significant effect coefficients. Unsupervised clustering of hub genes indicated that METTL14, HNRNPA2B1, YTHDF3, YTHDF2, YTHDC1, and YTHDC2 are potential discriminators in PCOS. The analysis of immune infiltration revealed a correlation between m6A regulators and immune cell levels, with METTL3 showing the most significant regulatory impact.
Conclusion
N 6 ‐methyladenosine RNA methylation regulators are intricately linked with the development of PCOS and may influence immune cell infiltration in affected individuals. This study enhances our understanding of the molecular interactions in PCOS and suggests potential biomarkers for diagnosis and targets for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
- Zheng's Gynecology Department, Kunshan Traditional Chinese Medicine Hospital, Suzhou, Jiangsu, China.
- Department of Pathology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
- Department of Gynecology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
ORCID-Profile: Lingli Shi, Lili Zhu, Lihong Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Jiangsu Province
- Gusu Health Talent Plan Research Project
- Youth Science and Technology Project of Suzhou
- Natural Science Foundation of Jiangsu province
- Multi-centre Clinical Research Project Fund for Major Diseases of Suzhou
- Science and Technology Development Plan of Suzhou
- Innovation project of State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture
Zitieren
APA
Xu, W., Shi, L., Lu, A., Cui, L., Qian, H., Wang, J., Tang, M., Zhu, L., & Wang, L. (2026). The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70376
Vancouver
Xu W, Shi L, Lu A, Cui L, Qian H, Wang J, et al. The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70376
BibTeX
@article{Xu2026,
author = {Xu, Wenting and Shi, Lingli and Lu, Aifang and Cui, Lijuan and Qian, Haiqing and Wang, Jiahui and Tang, Mengyu and Zhu, Lili and Wang, Lihong},
title = {The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70376}
}
EUVIMED